CTI BIOPHARMA CORP: cash_and_equivalents

Value{"amount": 70110000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2020-06-30)
Statuscurrent
EntityCTI BIOPHARMA CORP
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000891293-20-000051 · Open the official SEC filing →
Retrieved: 2026-08-19T08:57:46.154821+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000891293/cash-and-equivalents/2020-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/b8a61c93-1d5c-4b3d-b533-204a2c2b75c1

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies